Ted Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ted Wu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Stephen Morris Twigg
Greg Brown Diabetes and Endocrine Research Laboratory, Sydney Medical School (Central), Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
4 shared publications - Jencia Wong
Diabetes Centre, Royal Prince Alfred Hospital, Level 6 West, 50 Missenden Road, Sydney, NSW, 2050, Australia, 61 295155888, 61 295155820
3 shared publications - Margaret McGill
Diabetes Centre, Royal Prince Alfred Hospital, Level 6 West, 50 Missenden Road, Sydney, NSW, 2050, Australia, 61 295155888, 61 295155820
3 shared publications - Maria Constantino
Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
3 shared publications - Timothy L. Middleton
Diabetes Centre, Royal Prince Alfred Hospital, Level 6 West, 50 Missenden Road, Sydney, NSW, 2050, Australia, 61 295155888, 61 295155820
3 shared publications - Aravinda Thiagalingam
Westmead Applied Research Centre, Sydney Medical School, The University of Sydney, Level 5, Block K, Westmead Hospital, Hawkesbury Road, Westmead, 2145, Australia, +61 2 8890 3125, +61 2 8890 1960
2 shared publications
Latest Publications
- Open Access
- 8 August 2025
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 10, e68214
A Nurse-Led Telemonitoring Approach in Diabetes During the COVID-19 Pandemic: Prospective Cohort Study
Background: The utility of a nurse-led telemonitoring approach (NLTA) is yet to be firmly established in diabetes management. Objective: This study aims to examine the effect of a 12-month proactive NLTA on metabolic and psychological health indices in individuals with diabetes during the COVID-19 pandemic, and to evaluate it as a new diabetes model of care. Methods: The telemonitoring study group (TSG; n=91) comprised adults who had attended an Australian tertiary hospital diabetes center between January 2019 and March 2020. Telehealth surveillance contact with a diabetes nurse educator was subsequently maintained at approximately 3-month intervals over 12 months. Prospective surveillance measures included glycated hemoglobin A1c (HbA1c%), weight, adherence to healthy behaviors, and patient-reported outcomes of diabetes distress, anxiety, and depression using validated instruments. Metabolic changes were compared retrospectively with a comparison group who had not received telemonitoring contact during the study period (non-TSG; n=115). Results: The average participant age was 57.2 (SD 15) years; 63% (129/206) were male, 48% (99/206) had type 1 diabetes, 50% (104/206) had type 2 diabetes, and the mean HbA1c% was 8.1% (SD 1.4%). At the end of the 12-month study, the relative percentage reduction in unadjusted HbA1c% for the TSG cohort was significantly greater than that observed in the non-TSG cohort (4% vs 1%; P=.04). Following adjustment for baseline HbA1c%, a significant improvement in HbA1c% was observed in the TSG (P=.048) but not in the non-TSG (P=.61). TSG participants were 40% less likely (odds ratio 0.6, 95% CI 0.5‐0.7) to experience an unfavorable rise in HbA1c% compared to non-TSG participants, after adjusting for sex, age, prepandemic HbA1c%, ethnicity, diabetes type, and diabetes duration. The NLTA facilitated assessments of psychological risk, with elevated depression, anxiety and diabetes distress scores significantly increased in women and youth P<.001). Increasing anxiety measures were observed in those with high baseline anxiety scores (P<.001). Conclusions: A proactive diabetes NLTA is feasible with positive effects on glycemia and the potential to identify those at psychological risk for targeted intervention. In the context of increasing demand for diabetes-related resources, further study of an NLTA model of care is warranted.
- 8 August 2025
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 10, e68214
Open AccessA Nurse-Led Telemonitoring Approach in Diabetes During the COVID-19 Pandemic: Prospective Cohort Study
Background: The utility of a nurse-led telemonitoring approach (NLTA) is yet to be firmly established in diabetes management. Objective: This study aims to examine the effect of a 12-month proactive NLTA on metabolic and psychological health indices in individuals with diabetes during the COVID-19 pandemic, and to evaluate it as a new diabetes model of care. Methods: The telemonitoring study group (TSG; n=91) comprised adults who had attended an Australian tertiary hospital diabetes center between January 2019 and March 2020. Telehealth surveillance contact with a diabetes nurse educator was subsequently maintained at approximately 3-month intervals over 12 months. Prospective surveillance measures included glycated hemoglobin A1c (HbA1c%), weight, adherence to healthy behaviors, and patient-reported outcomes of diabetes distress, anxiety, and depression using validated instruments. Metabolic changes were compared retrospectively with a comparison group who had not received telemonitoring contact during the study period (non-TSG; n=115). Results: The average participant age was 57.2 (SD 15) years; 63% (129/206) were male, 48% (99/206) had type 1 diabetes, 50% (104/206) had type 2 diabetes, and the mean HbA1c% was 8.1% (SD 1.4%). At the end of the 12-month study, the relative percentage reduction in unadjusted HbA1c% for the TSG cohort was significantly greater than that observed in the non-TSG cohort (4% vs 1%; P=.04). Following adjustment for baseline HbA1c%, a significant improvement in HbA1c% was observed in the TSG (P=.048) but not in the non-TSG (P=.61). TSG participants were 40% less likely (odds ratio 0.6, 95% CI 0.5‐0.7) to experience an unfavorable rise in HbA1c% compared to non-TSG participants, after adjusting for sex, age, prepandemic HbA1c%, ethnicity, diabetes type, and diabetes duration. The NLTA facilitated assessments of psychological risk, with elevated depression, anxiety and diabetes distress scores significantly increased in women and youth P<.001). Increasing anxiety measures were observed in those with high baseline anxiety scores (P<.001). Conclusions: A proactive diabetes NLTA is feasible with positive effects on glycemia and the potential to identify those at psychological risk for targeted intervention. In the context of increasing demand for diabetes-related resources, further study of an NLTA model of care is warranted.
- Open Access
- 21 October 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23 (10) , e27263
An Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial
Background: Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. Conclusions: An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. Trial Registration: Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- 21 October 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23 (10) , e27263
Open AccessAn Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial
Background: Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. Conclusions: An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. Trial Registration: Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- Open Access
- 19 January 2021
- Published by JMIR Publications Inc. in JMIR Preprints
An Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial (Preprint)
BACKGROUND Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. CONCLUSIONS An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. CLINICALTRIAL Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- 19 January 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAn Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial (Preprint)
BACKGROUND Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. CONCLUSIONS An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. CLINICALTRIAL Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579